News

Bio Space
biospace. com > press-releases > pepfar-and-the-global-fund-make-additional-investment-in-gileads-lenacapavir-for-hiv-prevention-to-further-expand-access

PEPFAR and The Global Fund Make Additional Investment in Gilead's Lenacapavir for HIV Prevention to Further Expand Access

1+ day, 21+ hour ago  (279+ words) " Additional Commitment will Expand Access to Lenacapavir to Reach Another Million People Over the Next 3 Years " With approximately 1. 3 million new HIV infections globally each year, expanding access to highly effective, long-acting prevention options remains critical to changing the trajectory of…...

Bio Space
biospace. com > press-releases > almiralls-2025-results

Almirall's 2025 Results

1+ mon, 3+ week ago  (431+ words) Almirall meets guidance for 2025, delivering 12. 4% net sales growth and further pipeline progress, continuing its sustained growth trajectory with strong dermatology performance and commercial execution in Europe Carlos Gallardo, Almirall Chairman and CEO Almirall, S. A. (ALM), a global biopharmaceutical company based in…...